Abstract A rapid method is described for effectively removing immunoglobulin‐bearing cells from either primed or unprimed mouse spleen and lymph node cell suspensions. Incubation of cell suspensions in nylon wool columns for 45 min at 37 °C resulted in a 9 to 100‐fold depletion of immunoglobulin‐bearing cells and a complementary 1.5 to 2‐fold enrichment of…
European Journal of Immunology Template
Write in a clean editor, then format for European Journal of Immunology in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the European Journal of Immunology format
European Journal of Immunology is a peer-reviewed journal published by Wiley, covering T-cell and B-cell Immunology, Immune Cell Function and Interaction, Immunotherapy and Immune Responses.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." European Journal of Immunology 12 (3): 45–58.
Formats any DOI in European Journal of Immunology style. No sign-up. |
| Publishes research in | T-cell and B-cell Immunology Immune Cell Function and Interaction Immunotherapy and Immune Responses Monoclonal and Polyclonal Antibodies Research Immune Response and Inflammation |
| ISSN | 0014-2980 |
| Citation impact (2-yr) | 3.17 |
| h-index | 296 |
| i10-index | 14,167 |
| Total citations | 937,889 |
| Article processing charge | $4,120 |
| Top institutions publishing here | Inserm |
| Journal website | www3.interscience.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in European Journal of Immunology per year
Citation impact of European Journal of Immunology by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in European Journal of Immunology
Cell fusion techniques have been used to produce hybrids between myeloma cells and antibody-producing cells. The hybrid lines derived are permanently adapted to grow in tissue culture and are capable of inducing antibody-producing tumors in mice. Spleens from mice immunized against sheep red blood cells (SRBC) were fused to an 8-azaguanine-resistant clone (X63-Ag8) of MOPC…
In the spleens of young, adult mice there exist naturally occurring killer lymphocytes with specificity for mouse Moloney leukemia cells. The lytic activity was directed against syngeneic or allogeneic Moloney leukemia cells to a similar extent, but was primarily expressed when tested against in vitro grown leukemia cells. Two leukemias of non-Moloney origin were resistant…
A hybridoma clone which secretes a macrophage (M phi)-specific monoclonal antibody, F4/80, was produced by fusing spleen cells from a rat hyperimmunized with cultured thioglycollate-induced mouse peritoneal M phi with a mouse myeloma, NS1. Binding of antibody to primary cells and cell lines was detected by radioimmune indirect binding assay, autoradiography or fluorescence-activated cell sorter…
IL-6 is a pleiotropic cytokine involved in the physiology of virtually every organ system. Recent studies have demonstrated that IL-6 has a very important role in regulating the balance between IL-17-producing Th17 cells and regulatory T cells (Treg). The two T-cell subsets play prominent roles in immune functions: Th17 cell is a key player in…